A generic strategy for CRISPR-Cas9-mediated gene tagging

Nature Communications

Volumn 6, Issue , 2015, Pages

  Lackner, Daniel H ^a   Carré, Alexia ^a   Guzzardo, Paloma M ^a   Banning, Carina ^a   Mangena, Ramu ^b   Henley, Tom ^b   Oberndorfer, Sarah ^a   Gapp, Bianca V ^c   Nijman, Sebastian M B ^c   Brummelkamp, Thijn R ^d   Bürckstümmer, Tilmann ^a  

^a Vienna Biocenter   (Austria)

^b Molecular Biotechnology Center   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; BETA INTERFERON; CRISPR ASSOCIATED PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; FIBROBLAST GROWTH FACTOR 1; GENOMIC DNA; GUIDE RNA; INTERFERON REGULATORY FACTOR 9; LAMIN A; LUCIFERASE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TELOMERIC REPEAT BINDING FACTOR 1; BACTERIAL PROTEIN; CAS9 ENDONUCLEASE STREPTOCOCCUS PYOGENES; DEOXYRIBONUCLEASE I; DNA; ENDONUCLEASE; GREEN FLUORESCENT PROTEIN;

GENETIC MARKER; GENOMICS; HOMOLOGY; RNA;

ALLELE; ARTICLE; CELL CLONE; CELLULAR DISTRIBUTION; CLONAL CELL LINE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA SEQUENCE; DNA TRANSFECTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; PROMOTER REGION; REPORTER GENE; RNA CLEAVAGE; CELL LINE; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN GENOME; PLASMID; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BACTERIAL PROTEINS; CELL LINE; CRISPR-CAS SYSTEMS; DEOXYRIBONUCLEASE I; DNA; ENDONUCLEASES; GENES, REPORTER; GENETIC ENGINEERING; GENOME, HUMAN; GREEN FLUORESCENT PROTEINS; HUMANS; LUCIFERASES; MICROSCOPY, FLUORESCENCE; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, GUIDE;

EID: 84950283765     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10237     Document Type: Article

References (27)

1. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821 (2012).
2. Cho, S. W., Kim, S., Kim, J. M. & Kim, J. S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31, 230-232 (2013).
3. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
4. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
5. Mali, P., Esvelt, K. M. & Church, G. M. Cas9 as a versatile tool for engineering biology. Nat. Methods 10, 957-963 (2013).
6. Auer, T. O., Duroure, K., De Cian, A., Concordet, J. P. & Del Bene, F. Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res. 24, 142-153 (2014).
7. Maresca, M., Lin, V. G., Guo, N. & Yang, Y. Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Res. 23, 539-546 (2013).
8. Cristea, S. et al. In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration. Biotechnol. Bioeng. 110, 871-880 (2013).
9. Nakade, S. et al. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9. Nat. Commun. 5, 5560 (2014).
10. Hwang, W. Y. et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31, 227-229 (2013).
11. Carette, J. E. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340-343 (2011).
12. Essletzbichler, P. et al. Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line. Genome Res. 24, 2059-2065 (2014).
13. Hall, M. P. et al. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem. Biol. 7, 1848-1857 (2012).
14. Zhang, L., Gao, X., Wen, J., Ning, Y. & Chen, Y. G. Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. J. Biol. Chem. 281, 8607-8612 (2006).
15. Pichlmair, A. et al. IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA. Nat. Immunol. 12, 624-630 (2011).
16. Cao, X. M., Guy, G. R., Sukhatme, V. P. & Tan, Y. H. Regulation of the Egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts. J. Biol. Chem. 267, 1345-1349 (1992).
17. Shagin, D. A. et al. GFP-like proteins as ubiquitous metazoan superfamily: evolution of functional features and structural complexity. Mol. Biol. Evol. 21, 841-850 (2004).
18. Roblek, M. et al. Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W. PLoS ONE 5, e10604 (2010).
19. Kim, S. H., Kaminker, P. & Campisi, J. TIN2, a new regulator of telomere length in human cells. Nat. Genet. 23, 405-412 (1999).
20. Jae, L. T. et al. Virus entry. Lassa virus entry requires a trigger-induced receptor switch. Science 344, 1506-1510 (2014).
21. Blomen, V. A. et al. Gene essentiality and synthetic lethality in haploid human cells350, 1092-1096Science (2015).
22. Voets, E., Marsman, J., Demmers, J., Beijersbergen, R. & Wolthuis, R. The lethal response to Cdk1 inhibition depends on sister chromatid alignment errors generated by KIF4 and isoform 1 of PRC1. Sci. Rep. 5, 14798 (2015).
23. Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186-191 (2015).
24. Chari, R., Mali, P., Moosburner, M. & Church, G. M. Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach. Nat. Methods 12, 823-826 (2015).
25. Bae, S., Kweon, J., Kim, H. S. & Kim, J. S. Microhomology-based choice of Cas9 nuclease target sites. Nat. Methods 11, 705-706 (2014).
26. Hindson, B. J. et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem. 83, 8604-8610 (2011).
27. Kim, H. J., Lee, H. J., Kim, H., Cho, S. W. & Kim, J. S. Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. Genome research 19, 1279-1288 (2009).